Literature DB >> 2820234

Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin immunocytochemical studies with monoclonal anti-MFH antibodies.

H Iwasaki, T Isayama, H Johzaki, M Kikuchi.   

Abstract

Using whole cell antigens prepared from the established lines of human malignant fibrous histiocytoma (MFH), the authors have generated two different monoclonal antibodies (FU3 and FU4) by a mouse hybridoma technique. By indirect immunoperoxidase in frozen tissue sections, FU3 and FU4 revealed strong staining of perivascular mesenchymal cells and fibroblasts. In the spleen FU3 stained perivascular cells of the ellipsoids and the marginal zone of the lymph follicles. Macrophages in granulation tissues as well as monocytes and other blood cells in normal peripheral blood were uniformly negative for the antigen detected by FU3. Among various soft-tissue tumors, MFH and liposarcoma reacted strongly with FU3 and FU4, but synovial sarcoma revealed no reaction with either of the antibodies. Immunoelectron-microscopic studies demonstrated positive reactions with FU3 and FU4 on the surface of MFH cell membrane, which suggests that these antibodies recognized cell surface antigens. In conclusion, MFH shares antigenicity with perivascular mesenchymal cells and fibroblasts as well as liposarcoma. MFH and liposarcoma may have a common origin from the perivascular mesenchymal cells that are supposed to have a potential for multidirectional differentiation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820234      PMCID: PMC1899664     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Malignant soft tissue tumors of probable histiocytic origin (malignant fibrous histiocytomas): general considerations and electron microscopic and tissue culture studies.

Authors:  Y S Fu; G Gabbiani; G I Kaye; R Lattes
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

2.  [Malignant fibrous histiocytoma: a clinicopathologic study of 130 cases (author's transl)].

Authors:  H Hashimoto
Journal:  Fukuoka Igaku Zasshi       Date:  1979-10

3.  Malignant fibrous histiocytoma: an analysis of 200 cases.

Authors:  S W Weiss; F M Enzinger
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

4.  Malignant fibrous histiocytoma. Clinicopathologic and ultrastructural study of 12 cases.

Authors:  J Limacher; C Delage; R Lagacé
Journal:  Am J Surg Pathol       Date:  1978-09       Impact factor: 6.394

5.  Experimental approach to fibrous histiocytoma.

Authors:  T Yumoto; K Morimoto
Journal:  Acta Pathol Jpn       Date:  1980-09

6.  Malignant fibrous histiocytoma. A clinicopathologic study of 130 cases.

Authors:  M Enjoji; H Hashimoto; M Tsuneyoshi; H Iwasaki
Journal:  Acta Pathol Jpn       Date:  1980-09

7.  Benign and malignant fibrous histiocytomas of the soft tissues: functional characterization of the cultured cells.

Authors:  H Iwasaki; M Kikuchi; M Takii; M Enjoji
Journal:  Cancer       Date:  1982-08-01       Impact factor: 6.860

8.  Immunohistological study on malignant fibrous histiocytoma.

Authors:  A Inoue; K Aozasa; M Tsujimoto; M Tamai; F Chatani; H Ueno
Journal:  Acta Pathol Jpn       Date:  1984-07

9.  Characterization of tumor cells in malignant fibrous histiocytomas and other soft-tissue tumors, in comparison with malignant histiocytes. II. Immunoperoxidase study on cryostat sections.

Authors:  P J Roholl; J Kleyne; J A Van Unnik
Journal:  Am J Pathol       Date:  1985-11       Impact factor: 4.307

10.  Malignant fibrous histiocytoma: an ultrastructural study of eleven cases.

Authors:  M A Hoffman; G R Dickersin
Journal:  Hum Pathol       Date:  1983-10       Impact factor: 3.466

View more
  10 in total

Review 1.  Malignant fibrous histiocytoma: past, present, and future.

Authors:  A E Rosenberg
Journal:  Skeletal Radiol       Date:  2003-09-27       Impact factor: 2.199

2.  Intracranial cystic malignant fibrous histiocytoma in a child: sonographic and CT findings.

Authors:  M Castillo; P C Davis; Y D Takei; D G Schwartzberg; J C Hoffman
Journal:  Pediatr Radiol       Date:  1990

3.  FU-3 monoclonal antibody: a specific marker for malignant fibrous histiocytoma? An analysis of 32 malignant soft tissue and bone sarcomas.

Authors:  M J Perez-Bacete; A Llombart-Bosch
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents.

Authors:  Marc Becker; Claudine Graf; Marcus Tonak; Markus P Radsak; Tobias Bopp; Robert Bals; Rainer M Bohle; Matthias Theobald; Pol-Maria Rommens; Dirk Proschek; Thomas C Wehler
Journal:  Oncol Lett       Date:  2016-06-24       Impact factor: 2.967

5.  Transformation potential of bone marrow stromal cells into undifferentiated high-grade pleomorphic sarcoma.

Authors:  Qing Li; Hiroko Hisha; Takashi Takaki; Yasushi Adachi; Ming Li; Changye Song; Wei Feng; Satoshi Okazaki; Tomomi Mizokami; Junko Kato; Muneo Inaba; Naoki Hosaka; Masahiko Maki; Susumu Ikehara
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-21       Impact factor: 4.553

6.  Immunohistochemical, quantitative immunoelectron microscopic, and DNA cytofluorometric characterization of chemically induced rat malignant fibrous histiocytoma.

Authors:  T Tsuchiya; K Takahashi; M Takeya; Y Hosokawa; T Hattori; K Takagi
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

7.  Multiple tumor types appear in a transgenic mouse with the ras oncogene.

Authors:  R D Cardiff; A Leder; A Kuo; P K Pattengale; P Leder
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

8.  Pulmonary Artery Leiomyosarcoma Diagnosed without Delay.

Authors:  Motohisa Yamasaki; Yuki Sumi; Yumi Sakakibara; Meiyo Tamaoka; Yasunari Miyazaki; Hirokumi Arai; Katsuo Kojima; Fusahiko Itoh; Tomonari Amano; Yasuyuki Yoshizawa; Naohiko Inase
Journal:  Case Rep Oncol       Date:  2011-05-27

9.  The localization and distribution of cells labeled by a somatic stem cell-recognizing antibody (A3) in rat colon development; possible presence of a new cell type forming the intestinal stem cell niche.

Authors:  Hironobu Nishina; Chisa Katou-Ichikawa; Mizuki Kuramochi; Takeshi Izawa; Mitsuru Kuwamura; Jyoji Yamate
Journal:  J Toxicol Pathol       Date:  2018-09-09       Impact factor: 1.628

10.  Heterogeneity of cloned cell lines established from a transplantable rat malignant fibrous histiocytoma.

Authors:  J Yamate; M Tajima; M Togo; K Shibuya; M Ihara; S Kudow
Journal:  Jpn J Cancer Res       Date:  1991-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.